home slider 4 - Home

PrettyBrook Partners

Creating value in healthcare

and the life sciences.

Learn More
Medical - Home

Creating value in healthcare

and the life sciences.

Learn More

PrettyBrook Partners

Prettybrook Partners  invests in medical technology

products and businesses, as well as in healthcare services companies.

Idea Generation - Home

IDEA GENERATION

Generation of proprietary investment opportunites.

Qualification Process - Home

QUALIFICATION PROCESS

Screen investments for match with Prettybrook’s investment criteria.

Value Creation Methodology - Home

VALUE CREATION METHODOLOGY

Post-investment value creation program that includes specific operating and financial goals

Exit Planning - Home

EXIT PLANNING

Substantial merger and acquisition experience and extensive industry network results in creative and favorable exit planning.

PrettyBrook Partners

Creating value in healthcare and the life sciences

News

Recent News about PrettyBrook and its Portfolio

  • BusinessWire
    TRIMEDX to Acquire Aramark’s Healthcare Technologies Business
    September 20, 2018
  • NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance
    NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance
    August 13, 2018
  • Water Street Completes Sale of Premise Health
    Water Street Completes Sale of Premise Health
    August 13, 2018
Investment Criteria 1 - Home
Investment Criteria 2 - Home
Investment Criteria 3 - Home

INVESTMENT CRITERIA

What transaction types are we looking for?

Control-oriented leveraged buyouts of privately held businesses, corporate divisions, and public companies. Restructurings/recapitalizations of privately held businesses. Staged transitions of corporate entities. Going private transactions.

” We have chosen to join forces with Prettybrook because we believe that the new equity and the industry expertise the firm brings… positions us to capitalize on current trends in the healthcare marketplace. Our industry is changing and… management is convinced that with the right partner there are transformative opportunities that would benefit the company and its shareholders. We are very enthusiastic about the synergies of a partnership with Prettybrook. “

Portfolio Company

CEO

Investments

  • TriMedx

    Stuart Essig worked closely with Towerbrook in identifying and partnering with this company. TriMedx started as a hospital clinical engineering department focusing on reducing expenses, optimizing service and enhancing the patient experience through innovative medical equipment management programs. Today, TriMedx is recognized around the globe as a leader in healthcare technology management.

    Learn More
  • EndoStim

    Prettybrook co-invested with Wellington Partners in this company which has developed a unique, minimally-invasive implantable device designed to provide long-term reflux control by restoring normal esophageal function through low-energy personalized neurostimulation.

    Learn More
  • Beaver-Visitec

    Prettybrook co-invested with TPG Capital in this company. Beaver-Visitec International is focused on developing and manufacturing new, innovative and reliable products for a variety of ophthalmic and specialty microsurgical procedures.

    Learn More
  • G-Therapeutics

    Prettybrook made a direct investment, along with Wellington Partners, in this early stage company which is developing a therapy combining a spinal cord implant with robot-assisted training with an aim to accelerate and augment functional recovery of people with spinal cord injury.

    Learn More
  • ELAP

    Prettybrook co-invested with Water Street in this company. ELAP works with companies to design self-insured health plans and manage their medical claims. It conducts detailed audits on their medical bills and reprices them based on an analysis of the medical providers’ actual costs and Medicare rates.

    Learn More
  • Dynatronics Corporation

    We have chosen to join forces with Prettybrook because we believe that the new equity and the industry expertise the firm brings to Dynatronic’s positions us to capitalize on current trends in the healthcare marketplace. Our industry is changing and Dynatronic’s management is convinced that with the right partner there are transformative opportunities that would benefit the company and its shareholders. We are very enthusiastic about the synergies of a partnership with Prettybrook.

    Learn More
  • Breg

    Stuart Essig is Chairman of the Board of this leader in the sports medicine market, having participated in the leveraged buyout of the business with Water Street Capital Partners.

    Learn More
  • HealthEquitty

    Prettybrook made a direct investment in this emerging player in Health Savings Account management. Recently completed IPO.

    Learn More
  • Definiens

    Prettybrook made a direct investment in this tissue phenomics company. Recently was sold to AstraZeneca.

    Learn More
  • Temptime

    Prettybrook made a direct investment in this manufacturer of time-temperature indicators for sensitive vaccines, pharmaceuticals and medical devices.

    Learn More
  • Independent Clinical Services

    Prettybrook made a direct investment in this London based provider of staffing, complex care services and administrative outsourcing for clients in the healthcare sector.

    Learn More
  • Quanta

    Prettybrook made a direct investment in this emerging player in home dialysis.

    Learn More
  • Miamed

    Prettybrook has a direct investment in this medical education company.

    Learn More
  • Percsys

    Prettybrook has a direct investment in this emerging player in urologic devices.

    Learn More
  • Songbird

    Prettybrook participated in the leveraged acquisition of this disposable hearing aid manufacturer and Erin Enright acted as a board observer.

    Learn More
  • Stimwave

    Prettybrook is a Series A investor in this emerging leader in spinal cord stimulation.

    Learn More
  • Integra LifeSciences

    Stuart Essig serves as Chairman of the Board of Directors of this market leader in regenerative medicine. He previously served as Chief Executive Officer for 14 years.

    Learn More
  • LeeMedical

    Erin Enright acquired this manufacturer of bone-marrow needles in 2004 and served as President of the company. The Company was sold in 2013.

    Learn More
  • Boneshark

    Erin Enright acquired this manufacturer of disposable products for the spine market in 2011 and served as President of the company. The Company was sold in 2013.

    Learn More
  • InfuSystem

    Erin Enright participated in the IPO of HAPC, Inc as CFO in 2006, raising $100 million. The Company consummated the acquisition of InfuSystem Holdings in 2007.

    Learn More
  • SeaSpine

    Stuart Essig serves as a Director and Chair of the nominating and governance committee of this spinal products company.

    Learn More
  • Dohmen

    Prettybrook co-invested with Water Street in this company. Dohmens is the leading independent provider of commercialization services to life sciences companies, providing market access solutions that encompass patient support, channel, technology, and compliance services.

    Learn More
  • Key Surgical

    Prettybrook co-invested with Water Street in this company in order to create one of the world’s leading providers of sterile processing and operating room supplies.

    Learn More
  • iotaMotion

    Prettybrook participated in a seed financing round in this medical device startup spun out from the University of Iowa’s Otolaryngology Department, to fuel the development of novel robotic systems for cochlear implantation surgery.

    Learn More
  • viant - Home

    Prettybrook co-invested with Water Street Healthcare Partners and JLL Partners in Viant, creating a leading global services provider to the medical device industry.

    Learn More
  • keystone dental - Home

    Prettybrook co-invested with Accelmed in this company. Keystone Dental is an oral healthcare company that delivers advanced, easy-to-use implants, bio-materials and planning software for dental professionals focused on providing the most functional and most aesthetically pleasing outcomes possible.

    Learn More
  • Premise Health - Home

    Premise Health is the nation’s leading direct healthcare access company pioneering new models to deliver healthcare. Prettybrook co-invested when the company was formed in 2014 when Water Street partnered with Walgreen Co. to invest in its onsite healthcare subsidiary, Take Care Employer Solutions. It was simultaneously merged Take Care with CHS Health Services — bringing together two of the most experienced worksite providers in the industry.

    Learn More

Relationships

MAILING ADDRESS

512 West MLK Jr, Blvd #320
Austin, TX 78701

WE WORK AT

W 6th Street,
Austin, Texas